衰弱与5450例急性髓系白血病成人患者的医疗资源利用:加拿大安大略省基于人群的研究
该研究基于加拿大安大略省关联行政数据库,纳入2006—2023年接受化疗的5450例急性髓系白血病成人患者,用缺陷累积指数评估衰弱。多变量负二项回归显示,衰弱独立关联更高的总住院时长(RR 1.18)、医院/急诊就诊(RR 1.12)和ICU住院时长(RR 1.81);年龄≥65岁则与更低ICU利用相关(RR 0.60)。
要点
- 衰弱是AML患者医疗资源利用的独立驱动因素,尤其预测高 acuity 资源需求。
- 衰弱患者总住院时长RR 1.18、医院/急诊就诊RR 1.12、ICU住院时长RR 1.81。
- 年龄≥65岁与更低ICU利用相关(RR 0.60),提示ICU决策可能更受年龄驱动。
核心结论
- 衰弱是AML患者医疗资源利用的独立驱动因素,比实际年龄更能预测高 acuity 资源需求。
- 常规衰弱评估对资源分配、治疗强度指导和减少分诊偏倚至关重要。
研究设计与样本
- 基于加拿大安大略省关联行政数据库的回顾性队列研究,纳入5450例2006—2023年启动化疗的AML成人患者。
- 衰弱通过经验证的缺陷累积指数评估,采用多变量负二项回归调整年龄、性别和化疗强度。
主要发现
- 与fit患者相比,衰弱患者总住院时长率比RR 1.18、医院/急诊就诊率比RR 1.12、ICU住院时长率比RR 1.81。
- 年龄≥65岁与更低ICU利用相关(RR 0.60)。
关键数值与推荐
- 总住院时长RR 1.18,医院/急诊就诊RR 1.12,ICU住院时长RR 1.81,均为衰弱 vs fit。
- 年龄≥65岁 vs 更年轻者ICU利用RR 0.60。
临床怎么用
- 对AML患者常规进行衰弱评估,以指导资源分配和治疗强度决策。
- 避免仅依据实际年龄进行ICU分诊,应结合生理储备评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Frailty is a recognized prognostic factor in acute myeloid leukaemia (AML), yet its independent impact on healthcare resource utilization remains understudied. This study evaluated frailty's association with healthcare resource utilization (HRU) burden during the first year of AML treatment. We conducted a population-based retrospective cohort study using linked administrative databases in Ontario, Canada, involving 5450 AML adults (2006-2023) initiating chemotherapy. Frailty was assessed via a validated deficit-accumulation index. HRU outcomes-total-length of stay (LOS), intensive care unit (ICU)-LOS and hospital/emergency department (ED) visits-were measured as rates per person-year and their association with frailty measured as rate ratio (RR) using multivariable negative binomial regression, adjusting for age, sex and chemotherapy intensity. Frailty was independently associated with significantly higher HRU intensity. Compared to fit patients, frail patients demonstrated increased rates of total-LOS (RR 1.18), hospital/ED visits (RR 1.12) and, notably, ICU-LOS (RR 1.81). Conversely, advanced chronological age (≥65 years) correlated with lower ICU utilization (RR 0.60), suggesting critical care decisions may be more age-driven than based on physiological reserve. Frailty is a driver of HRU in AML, superiorly predicting high-acuity resource needs compared to chronological age. Routine frailty assessments are essential to inform resource allocation, guide treatment intensity, mitigate triage bias and improve value-based care.
引用
- Gupta G, Podolsky S, Liu N, et al. Frailty and health resource utilization in 5450 adults with acute myeloid leukaemia: A population-based study from Ontario, Canada. Br J Haematol. 2026. PMID: 42259647. doi:10.1111/bjh.70600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。